We are live on
!
Find out more
AWP
Accretive Wealth Partners Portfolio holdings
AUM
$356M
1-Year Est. Return
14.3%
This Fund
S&P 500
This Quarter
Est. Return
+0.26%
1 Year Est. Return
+14.3%
3 Year Est. Return
+53.96%
5 Year Est. Return
+65.44%
10 Year Est. Return
–
AUM
$236M
AUM Growth
-$3.5M
(-1.5%)
Cap. Flow
-$2.88M
Cap. Flow
% of AUM
-1.22%
Top 10 Holdings %
Top 10 Hldgs %
33.69%
Holding
134
New
3
Increased
41
Reduced
58
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$1.25M |
| 2 |
iShares Core Dividend Growth ETF
DGRO
|
+$962K |
| 3 |
West Pharmaceutical
WST
|
+$909K |
| 4 |
Merck
MRK
|
+$551K |
| 5 |
IBTF
iShares iBonds Dec 2025 Term Treasury ETF
IBTF
|
+$474K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$1.07M |
| 2 |
Humana
HUM
|
+$1.03M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$862K |
| 4 |
Teleflex
TFX
|
+$838K |
| 5 |
IBTE
iShares iBonds Dec 2024 Term Treasury ETF
IBTE
|
+$812K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.87% |
| 2 | Financials | 8.24% |
| 3 | Consumer Discretionary | 6.32% |
| 4 | Industrials | 5.16% |
| 5 | Communication Services | 4.65% |
Similar funds
SFP
PWAC
SWM
OFA
WKWM
WPC
CYG
EL
Accretive Wealth Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Accretive Wealth Partners held 134 positions worth $236M, down 1.5% from $239M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Accretive Wealth Partners's Q4 2024 filing shows 3 new, 41 increased, 58 reduced and 10 closed positions. Its largest new stake was iShares Core Dividend Growth ETF: 15,254 shares worth $936K. The largest sale was Crown Castle, an estimated $1.07M.
By sector, the portfolio is most concentrated in Technology at 9.9% of assets, up from 9.7% a quarter earlier, followed by Financials and Consumer Discretionary.
- Accretive Wealth Partners's largest Q4 2024 buy was iShares Core Dividend Growth ETF: 15,254 shares worth $936K.
- Accretive Wealth Partners added most to Thermo Fisher Scientific in Q4 2024, an estimated $1.25M increase.
- Accretive Wealth Partners's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $862K.
- Accretive Wealth Partners fully exited Crown Castle in Q4 2024, selling an estimated $1.07M.
- Accretive Wealth Partners's ten largest holdings make up 34% of its $236M portfolio in Q4 2024.
- Accretive Wealth Partners opened 3 new positions and closed 10 in Q4 2024.
- Accretive Wealth Partners's portfolio value fell 1.5% quarter-over-quarter to $236M.
Based on Accretive Wealth Partners's 13F filing for Q4 2024, filed 30 Jan 2025.